gliquidone has been researched along with c-peptide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonora, E; Cacciatori, V; Moghetti, P; Muggeo, M; Querena, M; Tosi, F; Travia, D; Zenere, M; Zoppini, G | 1 |
| Altomare, E; Di Reda, N; Giovine, A; Lasorsa, G; Procacci, V; Roberto, MG; Stufano, N; Vendemiale, G | 1 |
| Bocchino, C; Bonavita, M; Carleo, R; Dell'Aversano, R; Gatti, A; Giacometti, F; Monda, M | 1 |
1 trial(s) available for gliquidone and c-peptide
| Article | Year |
|---|---|
Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
Topics: Administration, Oral; Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose; Hexokinase; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Islets of Langerhans; Leukocytes, Mononuclear; Male; Middle Aged; Receptor, Insulin; Sulfonylurea Compounds | 1992 |
2 other study(ies) available for gliquidone and c-peptide
| Article | Year |
|---|---|
[Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gliclazide; Glucose; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Sulfonylurea Compounds | 1988 |
[Evaluation of the long-term effects of the administration of gliquidone in subjects with diabetes type II].
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Nitrogen; Sulfonylurea Compounds | 1987 |